ALLYRNA Pharmaceuticals
About ALLYRNA Pharmaceuticals
ALLYRNA, an innovative small molecule drug developer focused on first-in-class drug development, has established a unique platform for radiotherapy and immunotherapy sensitizers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $10.0M
- Funding stage: Seed
- Last round: Seed (Aug 2025)
Canonical: https://fsome.com/organization/allyrna-pharmaceuticals-66533 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.